FDA-APPROVED For Men with Erectile Dysfunction

Low incidence of adverse reactions seen in clinical trials

Adverse reactions reported ≥2% from 3 placebo-controlled clinical trials lasting 3 months1

safety1

Discontinuation rate due to adverse reactions from 3 placebo-controlled trials lasting 3 months1*

safety2

ADVERSE REACTIONS FROM A POST-RADICAL PROSTATECTOMY TRIAL (≥2%)1

chart3

 

Adverse reactions from a long-term, open-label extension trial (≥2%)1

chart1HCP_Adverse_events_2

 

 

HCP_Adverse_events_1
 

 

Savings Card